Copyright
©2010 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Hepatol. Nov 27, 2010; 2(11): 401-405
Published online Nov 27, 2010. doi: 10.4254/wjh.v2.i11.401
Published online Nov 27, 2010. doi: 10.4254/wjh.v2.i11.401
Clinical characteristics of null responders to Peg-IFNα2b/ribavirin therapy for chronic hepatitis C
Hideyuki Suzuki, Satoru Kakizaki, Norio Horiguchi, Takeshi Ichikawa, Ken Sato, Hitoshi Takagi, Masatomo Mori, Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Maebashi, Gunma 371-8511, Japan
Author contributions: Suzuki H and Kakizaki S, designed the study, analyzed and interpreted data, and drafted the manuscript; Horiguchi N, Ichikawa T, Sato K, and Takagi H, treated the patients and provided clinical data and performed the liver biopsy; and Mori M, supervised the work.
Correspondence to: Satoru Kakizaki, MD, PhD, Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, 3-39-15 Showa-machi, Maebashi, Gunma 371-8511, Japan. kakizaki@showa.gunma-u.ac.jp
Telephone: +81-27-2208127 Fax: +81-27-2208136
Received: August 12, 2010
Revised: November 4, 2010
Accepted: November 11, 2010
Published online: November 27, 2010
Revised: November 4, 2010
Accepted: November 11, 2010
Published online: November 27, 2010
Core Tip